Users’ Involvement in Regulating Contraceptive Innovation: The Design of Anti-Fertility Vaccines

Part of the Studies in Regulation book series (STUDREG)


The pharmaceutical industry brings to mind transnational commercial companies competing in the private sector at the behest of shareholders. However, it is important to appreciate that the industry takes other forms. For many years in Eastern Europe, it was part of the state and remains so in Cuba, which has evolved one of the most innovative and successful medical industries in the developing world. Even in the Western industrialized countries, where the private sector dominates the pharmaceutical industry, contraceptive product development increasingly involves publicly funded bodies as well as private enterprise. In this context potential users of the contraceptives have been able to become involved more than would normally be permitted by private companies controlling a strictly commercial venture. In this chapter, I examine how user involvement can shape and contribute to the ‘regulation’ of pharmaceutical innovation before products even reach the market.


Family Planning Abuse Potential Family Planning Programme Contraceptive Development Reproductive Scientist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 2003

Authors and Affiliations

There are no affiliations available

Personalised recommendations